Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Group-selective immunoassay

S A Yazynin1, S M Deyev

  • 1Department of Molecular Genetic Immunology, V.A. Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow.

Immunology Letters
|July 1, 1994
PubMed
Summary

A novel solid-phase immunoassay detects anti-digoxin monoclonal antibodies (Mabs). This method uses biotinylation and streptavidin-peroxidase, simplifying detection without secondary antibodies for hybridoma screening.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifunctional theranostic nanoplatform based on HER2-specific liposomes loaded with IR783 for simultaneous PTT/PDT therapy and optical bioimaging.

Nanomedicine : nanotechnology, biology, and medicine·2026
Same author

Uptake and Retention of Laser-synthesized Boron Nanoparticles in Tumor Cells and Fibroblasts.

Doklady. Biochemistry and biophysics·2026
Same author

The effect of dimeric bisbenzimidazoles on the activity of DNA repair enzymes TDP1, TDP2, PARP1 and PARP2.

Vavilovskii zhurnal genetiki i selektsii·2026
Same author

Synthesis and Pharmacokinetics of Nanosized NH<sub>2</sub>‑UiO‑66 (Zr) Metal-Organic Frameworks.

Doklady. Biochemistry and biophysics·2026
Same author

Targeted Radionuclide Detection of Malignant Tumors Using Affibody.

Acta naturae·2026
Same author

Targeted Nanoliposomes for the Delivery of Boronophenylalanine into HER2-Positive Cells.

Acta naturae·2025

Area of Science:

  • Immunochemistry
  • Biotechnology
  • Assay Development

Background:

  • Monoclonal antibodies (Mabs) are crucial in diagnostics and research.
  • Detecting specific Mabs, like anti-digoxin, requires sensitive and efficient methods.
  • Existing immunoassays can be complex, often necessitating multiple labeled antibodies.

Purpose of the Study:

  • To develop a simplified solid-phase immunoassay for detecting anti-digoxin Mabs.
  • To optimize the assay for hybridoma screening.
  • To eliminate the need for secondary labeled antibodies in the detection process.

Main Methods:

  • A solid-phase immunoassay using microtiter plates coated with a digoxin-human serum albumin conjugate (Dig-HSA).
  • Protection of free amino groups on the immunosorbent using glutaraldehyde cross-linking.
  • Biotinylation of anti-digoxin Mabs followed by detection with streptavidin-peroxidase conjugate.

Main Results:

  • The glutaraldehyde modification preserved the antibody-binding capacity of the immunosorbent.
  • The assay successfully detected anti-digoxin Mabs.
  • The method demonstrated efficiency without requiring a second labeled antibody.

Conclusions:

  • The developed solid-phase immunoassay is an effective method for anti-digoxin Mab detection.
  • This technique simplifies hybridoma screening by reducing assay steps.
  • The assay offers a sensitive and efficient alternative for antibody detection.

Related Experiment Videos